Ultralife (ULBI) Current Deferred Revenue (2010 - 2012)

Ultralife has reported Current Deferred Revenue for 3 years, with the latest figure at $1.9 million in Q4 2012.

• For the quarter ending Q4 2012, Current Deferred Revenue rose 3.64% year-over-year to $1.9 million; the trailing twelve-month figure through Dec 2012 stood at $1.9 million (up 3.64% YoY), and the FY2012 full-year result was $1.9 million, up 3.64% from the prior year.
• Current Deferred Revenue for Q4 2012 stood at $1.9 million, up from $1.8 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $2.9 million in Q4 2010, with the low at $1.8 million in Q4 2011.
• Average Current Deferred Revenue over 3 years is $2.2 million, with a median of $1.9 million recorded in 2012.
• Year-over-year, Current Deferred Revenue tumbled 38.14% in 2011 and rose 3.64% in 2012.
• Tracing ULBI's Current Deferred Revenue over 3 years: stood at $2.9 million in 2010, then plunged by 38.14% to $1.8 million in 2011, then increased by 3.64% to $1.9 million in 2012.
• The last three Current Deferred Revenue figures came in at $1.9 million (Q4 2012), $1.8 million (Q4 2011), and $2.9 million (Q4 2010), per Business Quant data.

Peer Comparison